Premium
Cutaneous Malignancies in Pediatric Solid Organ Transplant Recipients
Author(s) -
Fogel Alexander L.,
Miyar Maria,
Teng Joyce M. C.
Publication year - 2016
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12941
Subject(s) - medicine , immunosuppression , skin cancer , malignancy , organ transplantation , cancer , sarcoma , transplantation , dermatology , life expectancy , disease , population , intensive care medicine , oncology , pathology , environmental health
Abstract Pediatric organ transplant recipients ( POTR s) are at risk of developing malignancies due to a combination of immunosuppression, impaired DNA damage repair, and infection with oncogenic viruses. The most commonly developed malignancies in this population are skin cancers, which include nonmelanoma skin cancer, melanoma, Kaposi's sarcoma, and anogenital carcinoma. The literature shows that skin cancers account for 13% to 55% of all cancers that occur after transplantation. Given the increasing number and life expectancy of POTR s, prevention and management of skin cancer in these patients is essential, but there is a substantial knowledge gap in our understanding of the differences in skin cancer development, prevention, and management between POTR s and adult organ transplant recipients ( AOTR s), for whom more data are available. Substantial differences have been observed in the patterns of malignancy development between POTR s and AOTR s, and data specific to pediatric populations are needed. The objective of this review is to provide updated information on posttransplantation skin cancer development in POTR s, including epidemiologic research on transplant patients and disease development, medication management, surveillance, and education efforts.